Nicola Hanania, MD
Enriched profileBrown Foundation Professor of Medicine, Section of Pulmonary and Critical Care Medicine; Director, Airways Clinical Research Center · Baylor College of Medicine
Nicola Hanania is Brown Foundation Professor of Medicine, Section of Pulmonary and Critical Care Medicine; Director, Airways Clinical Research Center at Baylor College of Medicine. OpenAlex indexes 662 publications with 26,233 citations (h-index 77); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 16 Oct 2026
Nicola A. Hanania, MD, is Brown Foundation Professor of Medicine, Section of Pulmonary and Critical Care Medicine at Baylor College of Medicine, Houston, TX. The public record shows 662 publications with 26,233 citations (h-index 77), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory and Cough-Related Research. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 23 companies, 2 NIH-funded awards (2005–2014).
- Most recent indexed publication: 2024 · Drugs
- Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 289.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Sponsor: Johns Hopkins University
- Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Sponsor: Baylor College of Medicine
Industry payments
Updated 16 Oct 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202536 payments$154,962openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year20254 payments$139,550openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202521 payments$17,506openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
72.5%Corticosteroid37.8%Trelegy Ellipta46%Fluticasone Propionate31%Budesonide-Formoterol Fumarate12%Symbicort12%Part D<11 patientsbeta2-Adrenergic Agonist25.5%Albuterol Sulfate Hfa80%Ventolin Hfa20%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
13.1%Corticosteroid8.8%Prednisone100%Part D≥15 patientsProton pump inhibitor4.4%Pantoprazole Sodium100%Part D<11 patientsDermatology
9.2%Interleukin-4 Receptor alpha Antagonist9.2%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2005–2014 per NIH RePORTER. The latest:
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma
Baylor College of Medicine
FY2014$506,531U01AI095050 - Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma
Baylor College of Medicine
FY2013$1,656,438U01AI095050 - Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma
Baylor College of Medicine
FY2012$1,321,492U01AI095050
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impact of antiviral therapy on short- and long-term outcomes of patients with chronic obstructive pulmonary disease after influenza infection.
Influenza and other respiratory viruses
Article2023 - Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?
American journal of respiratory and critical care medicine
Comment2023 - COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA.
International journal of chronic obstructive pulmonary disease
Article2023 - Asthma and cardiovascular disease: A bidirectional association?
Respirology (Carlton, Vic.)
Comment2023
Most-cited works
by citation count (OpenAlex)- 01Lebrikizumab Treatment in Adults with Asthma1,506 citations2011
- 03Exploring the Effects of Omalizumab in Allergic Asthma889 citations2013
- 04Anxiety and Depression in COPD715 citations2008
- 05Radiation-Induced Lung Injury604 citations2019
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nicola-hanania-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/nicola-hanania-23607b25
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Nicola-Hanania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/Hananianick
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/asthma-australia_we-were-delighted-to-host-prof-nicola-hanania-activity-7340871495134416896-ShKx
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Board Certified
Internal Medicine (American Board of Internal Medicine)
- Board Certified
Pulmonary Disease (American Board of Internal Medicine)
- Board Certified
Critical Care Medicine (American Board of Internal Medicine)
- Fellow
Royal College of Physicians of Canada (FRCP(C))
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academiccme.com ↗ - Fellow
American College of Chest Physicians (FCCP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academiccme.com ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
Respiratory Medicine journal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →resmedjournal.com ↗ - Editorial Board Member
Pulmonary Pharmacology and Therapeutics (Elsevier)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →journals.elsevier.com ↗ - Associate Editor / Asthma Section Editor
Current Opinion in Pulmonary Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcm.edu ↗ - Associate Editor
Lung (journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcm.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →touchrespiratory.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →touchrespiratory.com ↗
Secondary affiliations
appointments beyond the home institution- Chief
Section of Pulmonary, Critical Care and Sleep Medicine, Ben Taub Hospital, Houston, TX
- Faculty Senator
Baylor College of Medicine
- Principal Investigator
American Lung Association Airways Clinical Research Center, Baylor College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
Media & interviews
press, podcasts and appearances- HCPLive video interview series (multiple, 2023-2025): asthma/COPD precision medicine
IL-33 pathway in COPD, dupilumab and COPD outcomes, triple therapy and biologics in COPD
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - "A Fresh Look at Asthma with Nicola Hanania, MD"
Houston Methodist Academic Institute video portal
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →watch.houstonmethodist.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
- CHEST Physician: "Experts take sides in controversies on asthma-COPD overlap and treatable traits"
took pro position on asthma-COPD overlap
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chestphysician.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
Sankar Navaneethan, MD
Baylor College of Medicine
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital